07/02/08, Bayer HealthCare Bayer HealthCare Completes Acquisition of Western OTC Cough and Cold Business of Topsun Science and Technology Significantly Strengthens Consumer Care Division’s Business in High Growth Chinese OTC Market External Link: more
07/02/08, Cardiology/Hematology Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen Phase 1 clinical testing expected to commence in third quarter of 2008 / Transaction includes license to Maxygen’s novel biotechnology research platform External Link: more
06/30/08, Research & Development Rivaroxaban is First Novel Oral Anticoagulant to Significantly Reduce the Composite Outcome of Symptomatic VTE and Death Rivaroxaban shows superior efficacy to enoxaparin for this clinical outcome with a comparable safety profile / Pre-specified analysis of pooled data from RECORD 1-3 studies involving nearly 10,000 pa... External Link: more
Image: Arthur J. Higgins, Chairman of the Board of Management of Bayer HealthCare AG
Research-based pharmaceutical industry in Europe to celebrate 30. anniversary at Annual Meetings
Review of success and first results of EFPIA’s AIMS roadmap
In his address on the occasion of EFPIA’s 30th anniversary, EFPIA President and CEO of Bayer Healthcare Arthur Higgins showcased some of the historic milestones amo...
more